Shots:

• Elanco has received the US FTC’s approval for its acquisition of Bayer Animal Health- representing the final antitrust clearance needed to complete the transaction- which continues track for closing at the beginning of August
• The FTC’s approval follows divestiture of global rights for Osurnia to treat otitis externa in dogs- US rights for Capstar that kills fleas in dogs and cats- and StandGuard that treat horn fly and lice control in beef cattle
• In addition to FTC approval- Elanco has received antitrust clearance for the transaction from the EC- Australia- Brazil- Canada- China- Colombia- New Zealand- South Africa- Turkey- Ukraine- and Vietnam

­ Ref: Elanco | Image: Seeking alpha